CD19 and systemic sclerosis: Initially, we characterized major immune cell lineages by assessing the frequency of T cells (CD3+), B cells (CD19+), monocytes (CD14+), and NK/ILCs (CD3−CD14−CD19−) in PBMCs from SSc patients and HC.